Enhancing doxorubicin's anticancer impact in colorectal cancer by targeting the Akt/Gsk3β/mTOR-SREBP1 signaling axis with an HDAC inhibitor.
Saved in:
| Title: | Enhancing doxorubicin's anticancer impact in colorectal cancer by targeting the Akt/Gsk3β/mTOR-SREBP1 signaling axis with an HDAC inhibitor. |
|---|---|
| Authors: | Huaxin Zhao1, Yanling Wu1, Soo Mi Kim1,2 soomikim@jbnu.ac.kr |
| Source: | Korean Journal of Physiology & Pharmacology. May2025, Vol. 29 Issue 3, p321-335. 15p. |
| Database: | Academic Search Ultimate |
| ISSN: | 12264512 |
|---|---|
| DOI: | 10.4196/kjpp.24.274 |
